EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity

Lee Machado iD, Leanne Jones, Sonika Divakar, Michael Naidoo, Karen Anthony iD

FEBS Open Bio · 2026

DOI: 10.1002/2211-5463.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Open Bio, 2026. Verfasst von Lee Machado und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Physical Activity and Life Sciences, University of Northampton, UK. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Dystrophin, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evidence implicates the Duchenne muscular dystrophy gene ( DMD ) in tumorigenesis, but survival trends are inconsistent. To resolve this, we conducted a comprehensive global analysis of DMD expression and survival outcomes across 33 tumour types using bulk RNA sequencing data from The Cancer Genome Atlas. We examined the impact of total DMD , individual transcript and dystrophin‐associated protein complex (DAPC) gene expression levels on overall survival using Kaplan–Meier analysis, Cox proportional hazard modelling and pathway analysis. DMD expression was significantly associated with survival in nine cancers after Bonferroni correction (α = 0.0015), with high expression linked to either improved or worsened outcomes depending on cancer type. The most abundant DMD transcript, Dp71ab, mirrored total DMD trends, distinguishing two tumour groups with opposing survival associations. Hierarchical clustering suggests these divergent effects may be linked to a subset of signalling and adhesion‐related DAPC components. Our findings indicate that DMD does not act uniformly as an oncogene or tumour suppressor. Instead, we propose a context‐dependent dual model whereby high DMD expression is tumour suppressive in aggressive cancers and oncogenic in less aggressive tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneDystrophinNeoplasmsHumansCarcinogenesisGene Expression Regulation, NeoplasticKaplan-Meier EstimateGenes, Tumor SuppressorOncogenes

Stichwörter der Autor:innen

Dp71Duchennecancerdystrophindystrophin‐associated protein complex

Substanzen

DystrophinDMD protein, human

Autor:innen und Institutionen

  • Centre for Physical Activity and Life Sciences, University of Northampton, UK.
  • Department of Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, UK.

ORCID-Profile: Lee Machado, Karen Anthony

Zitieren

APA

Machado, L., Jones, L., Divakar, S., Naidoo, M., & Anthony, K. (2026). A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70109

Vancouver

Machado L, Jones L, Divakar S, Naidoo M, Anthony K. A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70109

BibTeX
@article{Machado2026,
  author = {Machado, Lee and Jones, Leanne and Divakar, Sonika and Naidoo, Michael and Anthony, Karen},
  title = {A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity},
  journal = {FEBS Open Bio},
  year = {2026},
  doi = {10.1002/2211-5463.70109}
}
Kostenlos starten →